Sanofi
SNY
#164
Rank
HK$941.13 B
Marketcap
HK$385.57
Share price
1.29%
Change (1 day)
6.86%
Change (1 year)

Sanofi is a French pharmaceutical company created in 2004 by the merger of Sanofi-Synthรฉlabo and Aventis. With sales of EUR 36.1 billion in 2019 and more than 100,000 employees worldwide, Sanofi is one of the largest pharmaceutical companies in the world in terms of sales.

EPS for Sanofi (SNY)

EPS in 2025 (TTM): HK$28.82

According to Sanofi's latest financial reports the company's current EPS (TTM) is HK$28.85. In 2023 the company made an earnings per share (EPS) of HK$18.04 a decrease over its 2022 EPS that were of HK$21.94.

EPS history for Sanofi from 2012 to 2025

Annual EPS

Year EPS Change
2025 (TTM)HK$28.82
2023HK$18.04-17.77%
2022HK$21.94
2017HK$28.5580.47%
2016HK$15.8211.92%
2015HK$14.14-16.07%
2014HK$16.8415.33%
2013HK$14.60-22.64%
2012HK$18.88

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Merck
MRK
HK$59.11 104.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
HK$13.39-53.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$23.12-19.85%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.29 98.61%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
GlaxoSmithKline
GSK
HK$27.99-2.96%๐Ÿ‡ฌ๐Ÿ‡ง UK
Teva Pharmaceutical Industries
TEVA
HK$4.90-83.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Johnson & Johnson
JNJ
HK$81.27 181.71%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$159.73 453.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Novo Nordisk
NVO
HK$27.35-5.19%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Abbott Laboratories
ABT
HK$62.72 117.42%๐Ÿ‡บ๐Ÿ‡ธ USA